Literature DB >> 21605809

Pathogenesis of bullous pemphigoid.

Hideyuki Ujiie1, Wataru Nishie, Hiroshi Shimizu.   

Abstract

Bullous pemphigoid, the most common autoimmune blistering disease, is induced by autoantibodies against type XVII collagen. Passive transfer of IgG or IgE antibodies against type XVII collagen into animals has revealed not only the pathogenicity of these antibodies but also the subsequent immune responses, including complement activation, mast cell degranulation, and infiltration of neutrophils and/or eosinophils. In vitro studies on ectodomain shedding of type XVII collagen have also provided basic knowledge on the development of bullous pemphigoid. The pathogenic role of autoreactive CD4+ T lymphocytes in the development of the pathogenic autoantibodies to type XVII collagen should also be noted.
Copyright © 2011 Elsevier Inc. All rights reserved.

Mesh:

Substances:

Year:  2011        PMID: 21605809     DOI: 10.1016/j.det.2011.03.008

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  7 in total

Review 1.  Mechanisms of Autoantibody-Induced Pathology.

Authors:  Ralf J Ludwig; Karen Vanhoorelbeke; Frank Leypoldt; Ziya Kaya; Katja Bieber; Sandra M McLachlan; Lars Komorowski; Jie Luo; Otavio Cabral-Marques; Christoph M Hammers; Jon M Lindstrom; Peter Lamprecht; Andrea Fischer; Gabriela Riemekasten; Claudia Tersteeg; Peter Sondermann; Basil Rapoport; Klaus-Peter Wandinger; Christian Probst; Asmaa El Beidaq; Enno Schmidt; Alan Verkman; Rudolf A Manz; Falk Nimmerjahn
Journal:  Front Immunol       Date:  2017-05-31       Impact factor: 7.561

2.  [Bullous pemphigoid].

Authors:  F Schulze; M Kasperkiewicz; D Zillikens; E Schmidt
Journal:  Hautarzt       Date:  2013-12       Impact factor: 0.751

Review 3.  Bullous pemphigoid.

Authors:  Denise Miyamoto; Claudia Giuli Santi; Valéria Aoki; Celina Wakisaka Maruta
Journal:  An Bras Dermatol       Date:  2019-05-09       Impact factor: 1.896

Review 4.  Bullous pemphigoid in diabetic patients treated by gliptins: the other side of the coin.

Authors:  Karim Chouchane; Giovanni Di Zenzo; Dario Pitocco; Laura Calabrese; Clara De Simone
Journal:  J Transl Med       Date:  2021-12-20       Impact factor: 5.531

5.  Bullous pemphigoid following COVID-19 vaccine: An autoimmune disorder.

Authors:  Aneesh Rai; Govinda Khatri; Mohammad Mehedi Hasan
Journal:  Ann Med Surg (Lond)       Date:  2022-07-31

6.  Bullous Pemphigoid Complicated by Sepsis.

Authors:  Dipal Shah; Aanchal Shah; Viet S Nguyen; Michael Falgiani; Latha Ganti
Journal:  Cureus       Date:  2022-09-04

7.  The association between clinical and laboratory findings of bullous pemphigoid and dipeptidyl peptidase-4 inhibitors in the elderly: a retrospective study.

Authors:  Zrinka Bukvić Mokos; Mikela Petković; Anamaria Balić; Branka Marinović
Journal:  Croat Med J       Date:  2020-04-30       Impact factor: 1.351

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.